Predicting Alzheimer’s Progression
AI Tool 3x More Accurate at Predicting Alzheimer’s Progression than Current Tests
Early diagnosis of dementia and Alzheimer’s can be challenging because both conditions share many symptoms with age-related cognitive loss. Researchers at the University of Cambridge have created an artificial intelligence (AI) tool that can forecast if a person with early dementia symptoms would remain stable or develop Alzheimer’s. It was three times more accurate than … Continue reading "AI Tool 3x More Accurate at Predicting Alzheimer’s Progression than Current Tests"
Kisunla, The Newly FDA-Approved Alzheimer's Drug
What Should You Know About Kisunla, The Newly FDA-Approved Alzheimer’s Drug
The Food and Drug Administration approved a new medication on July 2, 2024, for Alzheimer’s treatment [1]. The drug, Kisunla, is the third in a new class of treatments to slow disease progression. It bears similarities to Leqembi, a medication that was authorized for use in early-stage Alzheimer’s patients last year [2]. Another drug in … Continue reading "What Should You Know About Kisunla, The Newly FDA-Approved Alzheimer’s Drug"